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Abstract
 
Control of CD8
 
 
 
 transcription during development of 
 
 
 
/
 
 
 
 T cell receptor (TCR) T lympho-
cytes is mediated by at least two distinct stage-specific cis-acting transcriptional mechanisms
(i.e., enhancers). On the CD8
 
 
 
 
 
/
 
 
 
knockout (KO) background, cis-mechanism I and cis-
mechanism II together mediate appropriate stage- and sublineage-specific transgenic (Tg)
CD8
 
 
 
 expression and “rescue” development of peripheral CD8
 
 
 
 single-positive (SP) cytotoxic
T lymphocytes (CTLs). In contrast, on the wild-type (WT)/CD8
 
 
 
/
 
 
 
 or CD8
 
 
 
 
 
/
 
 
 
KO back-
grounds, a CD8
 
 
 
 Tg directed by cis-mechanism I alone is activated during the double negative
[DN] to double positive [DP] transition and expressed up to the CD3
 
low/intermediate
 
 DP stage but
not in more mature DP or SP thymocytes or peripheral T cells. As loss of cis mechanism I ac-
tivity occurs around the onset of positive selection, it is possible that events associated with
TCR/major histocompatibility complex (MHC) interactions and selection are involved in ini-
tiating these changes in CD8
 
 
 
 transcription. To examine this issue, phenotypic and functional
studies were performed for thymocytes and T cells of CD8
 
 
 
 
 
/
 
 
 
KO mice that expressed a
CD8
 
 
 
 Tg under control of cis-mechanism I only. Despite loss of CD8
 
 
 
 expression at the DP
CD3
 
low/intermediate
 
 stage, increased populations of mature CD3
 
hi
 
CD4
 
 
 
CD8
 
 
 
 thymocytes and
CD3
 
 
 
CD4
 
 
 
CD8
 
 
 
 peripheral T cells were detected. By several criteria, including MHC class
I–restricted antigen recognition, these cells have at least partially undergone positive and nega-
tive selection. Therefore, initiation of selection and sublineage commitment are determined
before loss of cis-mechanism I–mediated control of CD8
 
 
 
 transcription. Further, CD8 expres-
sion beyond the CD3
 
low/intermediate
 
 DP thymic stage is not essential for CTL development in
vivo or function.
Key words: CD8 • gene expression • stage-speciﬁc regulation • thymic selection • sublineage 
commitment
 
Introduction
 
The strict correlation among peripheral 
 
 
 
/
 
 
 
 TCR T lym-
phocytes of CD8 expression with specificity for MHC class
I, and CD4 expression with specificity for MHC class II, is
established during thymic development (1, 2). As thy-
mocytes mature, they go through progressive stages of CD4
and CD8 expression, from initially expressing neither (i.e.,
the double-negative [DN] stage), to coexpressing both (the
double-positive [DP] stage), to expressing one or the other
(the single positive [SP] stage) (3, 4). The DP to SP transition
depends in part on TCR/MHC interactions and is charac-
terized by positive and negative selection of the TCR reper-
toire, loss of one or the other coreceptor, and commitment
to the cytotoxic or helper sublineage (1–4). Although some
progress has been made in defining intermediate subpopula-
tions (5, 6) and signaling pathways (7) in the DP to SP tran-
sition, their relationships and contributions to T cell devel-
opment at the transcriptional level are not yet clear. As CD8
and CD4 regulation are so tightly coupled to events of thy-
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mic differentiation, identification of their transcriptional
control mechanisms will contribute to resolving these issues.
CD8 and CD4 are known to function during thymic se-
lection and in the peripheral response to antigen (1–6). By
binding conserved regions on class I and class II proteins
respectively, these molecules stabilize cell interactions and
contribute to signaling (3, 4, 8). Their importance in selec-
tion is illustrated by impaired development of cytotoxic
and helper T cells in CD8- and CD4-deficient (i.e.,
knock-out [KO]) mice (9). Aside from the above, it is not
known if either coreceptor serves additional functions be-
fore or after selection in the thymus or in peripheral T cells
before encounter with antigen.
With these issues in mind, we have investigated transcrip-
tional regulation of CD8 by assessing the patterns of expres-
sion and function of a series of mouse CD8
 
 
 
 gene con-
structs in thymocytes and T cells of transgenic (Tg) mice
that are wild type (WT) or deficient (i.e., KO) for endoge-
nous CD8
 
 
 
 (10). The CD8
 
 
 
 Tg constructs contained vary-
ing amounts of 5
 
 
 
 and 3
 
 
 
 flanking DNA to permit identifi-
cation of important transcriptional control sequences (i.e.,
enhancers) within the CD8 locus. Although CD8
 
 
 
 (Lyt2.1)
constructs with up to 12 kb of 5
 
 
 
 and 4.5 kb of 3
 
 
 
 flanking
DNA were not expressed in T or non-T cells of Tg mice,
inclusion of a 40-kb upstream segment led to expression in
thymocytes and peripheral T cells in a pattern paralleling
endogenous CD8
 
 
 
 (Lyt 2.2) (10). Thus, this 40-kb region
contains transcriptional enhancers able to direct stage- and
sublineage-specific expression of CD8
 
 
 
 in developing and
mature 
 
 
 
/
 
 
 
 TCR T cells (10, 11). Studies to characterize
these cis-sequences showed that a 17-kb 5
 
 
 
 subfragment di-
rects Tg CD8
 
 
 
 expression during the DN to DP transition
and up to the CD3
 
low/intermediate
 
 DP stage but not in more
mature DP or SP thymocytes or T cells (10). These find-
ings, with results from others (11, 12), suggest that thymic
CD8
 
 
 
 expression is mediated by at least two distinct stage-
specific cis-acting transcriptional control mechanisms: cis-
mechanism I resides within the 17-kb subfragment and is
important for directing CD8
 
 
 
 expression up to an early/in-
termediate DP stage; cis-mechanism II is located down-
stream of this region and is important for expression after
this stage in more mature DP and SP thymocytes and CD8
 
 
 
SP T cells (10–14). As the stage when cis-mechanism I is no
longer active is around the onset of positive selection, it is
possible that these changes in CD8
 
 
 
 transcriptional control
are causally linked to events of selection. To investigate this
issue, we performed phenotypic and functional analyses of
thymic subpopulations and peripheral T cells of mice ex-
pressing Tg CD8
 
 
 
 under control of cis-mechanism I alone
(and in the absence of endogenous CD8
 
 
 
). Our results in-
dicate that at least some aspects of selection and sublineage
commitment precede loss of cis-mechanism I activity.
 
Materials and Methods
 
CD8
 
 
 
 Tg Mice, Inbred Mice, and KO Mice.
 
The CD8
 
 
 
 (Lyt2.1)
DNA constructs and Tg mice were described previously (10).
Briefly, fragment C was 22 kb and contained the CD8
 
 
 
 gene
with 12 and 4.5 kb of 5
 
 
 
 and 3
 
 
 
 flanking DNA. As this CD8
 
 
 
gene was a hybrid of the first three exons of Lyt-2.1 and the last
two exons of Lyt-2.2, the encoded protein is recognized by anti–
Lyt-2.1 mAb (10). Fragment D was an upstream 40-kb fragment
that overlapped the 5
 
 
 
 end of fragment C. Coinjection of frag-
ments C and D led to cointegration at a single chromosomal site
and appropriate expression of TgCD8
 
 
 
 in the thymus and pe-
riphery (10). These mice are called TgCD8
 
 
 
(C
 
 
 
D). Fragment F
was a 17-kb fragment encompassing the 5
 
 
 
 region of fragment D.
Tg mice carrying fragments C and F at a single site are
TgCD8
 
 
 
(C
 
 
 
F) (10). Tg lines were established by 8–10 back-
crosses with C57BL/6J (H-2
 
b
 
; Lyt2.2) mice.
To establish each Tg strain on CD8
 
 
 
 
 
/
 
 
 
KO, TgCD8
 
 
 
(C
 
 
 
D), or TgCD8
 
 
 
(C
 
 
 
F), offspring (on B6) were backcrossed
6–8 times with homozygous CD8
 
 
 
(Lyt2.2) KO mice (on B6)
(9). The resulting mice are called TgCD8
 
 
 
(C
 
 
 
D)/CD8
 
 
 
 
 
/
 
 
 
KO
and TgCD8
 
 
 
(C
 
 
 
F)/CD8
 
 
 
 
 
/
 
 
 
KO.
C57BL/6J (H-2
 
b
 
; B6), DBA/2J (H-2
 
d
 
), and B6.CH-2bm1(H-
2K
 
bm1
 
) (15) mice were from The Jackson Laboratory. CD8
 
 
 
 
 
/
 
 
 
KO
mice (9) were from Dr. T. Mak (Amgen Institute and Ontario
Cancer Institute, Ontario, Canada). Mice were housed in a
pathogen-free facility at The Hospital For Sick Children accord-
ing to the Canadian Council of Animal Care.
 
Flow Cytometry.
 
Cell suspensions from thymii, spleens, or
LNs from 6–8-wk-old mice were used for flow cytometry as de-
scribed (10). mAbs included: anti–Lyt2.1 and anti–Lyt-2.2 (10);
anti-CD8
 
 
 
/Lyt2-biotin (BD PharMingen; reacts with Lyt2.1 and
Lyt2.2); anti–CD4-PE or -allophycocyanin (APC) (BD Phar-
Mingen); anti–CD3
 
 
 
-biotin, -PerCP (BD PharMingen), or -QR
(Sigma-Aldrich). Staining with unconjugated mAbs was detected
with FITC-secondary immunoglobulins (Accurate Scientific
Corp.) as indicated. Biotinylated antibodies were detected with
streptavidin (SA)-FITC (BD PharMingen) or SA-QR (Sigma-
Aldrich). The tetramer for flu nucleoprotein (NP) peptide 366–374
with H-2D
 
b
 
 was from the National Institutes of Health/
National Institute of Allergy and Infectious Diseases Tetramer
Facility. Lymphocytes were identified by forward and side scatter
and 10,000 gated events were collected on a FACScan™ flow cy-
tometer or a FACSCalibur™. Data analysis was with CELL-
Quest™ software (Becton Dickinson).
 
Cell-mediated Lympholysis Assay.
 
Cell-mediated lympholysis
(CML) assays were performed as described (16). Responder LN
cells (LNCs) were stimulated with irradiated DBA (H-2
 
d
 
) spleen
cells for 5 d and used in 
 
51
 
Cr-release assays with concanavalin
A–stimulated spleen cell targets (16). Specific lysis was [(ex-
perimental 
 
 
 
 spontaneous release)/(maximal 
 
 
 
 spontaneous re-
lease)] 
 
 
 
 100%.
 
Skin Grafts.
 
8–10-wk-old mice were given full thickness skin
grafts as described (16) from tails of adult sex-matched bm1 or
control B6 mice. After removal of bandages on day 7, grafts were
evaluated daily for evidence of rejection. Grafts were considered
rejected when less than 10% of the graft bed contained viable
grafted skin.
 
Influenza A Virus, Peptides, and Cytotoxicity Assays.
 
Mice
were infected by intraperitoneal injection of 300 HAU of influ-
enza A virus X-31 (Charles River Laboratories [Spafas]) in PBS.
In H-2
 
b
 
 mice, the dominant anti-flu CTL response is directed at
NP peptide amino acid 366–374 (NP366–374) with H-2D
 
b
 
 (17).
Peptides were from Research Genetics.
Spleen cells from mice infected 3 wk earlier were restimulated
in vitro for two 6–7-d periods with 0.1 
 
 
 
M NP366–374. Autolo-
gous peptide-pulsed spleen cells were the source of APCs and T 
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cells for the first period. For the second period, peptide-pulsed ir-
radiated (2,000 rads) H-2
 
b
 
/CD8
 
 
 
/
 
 
 
KO spleen cells served as
APCs. For initial stimulation, 
 
 
 
70 
 
  106 cells were cultured in 10
ml  -MEM (GIBCO BRL) containing 10% FCS (Sigma-Aldrich),
10 mM Hepes, 5   10 5 M  -mercaptoethanol,  penicillin/
streptomycin (GIBCO BRL), and 5 U/ml of mouse IL-2 (CTL
medium). After 6–7 d, viable cells were harvested and restimu-
lated. Cell aliquots were stained on the indicated day for CD3 and
CD4. On the day of 51Cr-release assay, 106 EL4 cells (H-2b) were
labeled with Na51CrO4 (16), then pulsed with 0.1  M of NP366–
374 or a control peptide. Effectors were incubated with targets at
various E/T ratios for 4 h. Supernatants were harvested and
counted. Specific lysis was [(experimental   spontaneous release)/
(maximal   spontaneous release)]   100% (reference 16).
Results
Stage-specific Expression of CD8 in Developing Thy-
mocytes. Our previous studies showed that, although
mouse CD8  gene constructs with 12 kb of 5  and 4.5 kb
of 3  flanking DNA (fragment C in reference 10) were
not expressed in T cells of Tg mice, inclusion of the adja-
cent 40-kb upstream segment from the chromosomal lo-
cus (fragment D) gave rise to appropriate TgCD8  ex-
pression in DP and SP thymocytes and peripheral
CD8 CD4  T cells (TgCD8 [C D]; reference 10).
Thus, this 40-kb region contains transcriptional enhancers
able to direct stage- and sublineage expression of CD8  in
developing and mature  /  TCR T cells, consistent with
results of others (11). A 17-kb 5  subfragment of D (i.e.,
F) was subsequently found to direct expression of CD8 
fragment C (TgCD8 [C F]) in the thymus up to the
CD3low/intermediate DP stage, but not in more mature DP or
SP thymocytes or peripheral T cells (10). These results in-
dicate that distinct cis-elements direct expression of CD8 
before versus after this CD3low/intermediate DP stage (10). Al-
though these initial studies with the (C F) Tg were in Tg
mice WT for endogenous CD8  (Lyt2.2 allele), a similar
distribution of thymic expression was observed for this Tg
bred onto the CD8  / KO background which is defi-
cient for surface expression of CD8  and CD8  in the
thymus and periphery and lacks detectable CTLs (9) (not
shown). Therefore, our results show the CD8(C F) con-
struct directs expression of surface protein up to the
CD3inter stage but not beyond, and coexpression of endog-
enous CD8 does not influence this distribution. Due to
the unknown time-lag between changes in transcription
being represented at the cell surface, the loss of
TgCD8(C F) surface protein after the CD3inter stage im-
Figure 1. Three-color flow cytometry of
CD4 and CD8 expression on CD3hi thymocytes
of TgCD8 (C F) mice in the absence of en-
dogenous CD8 . Thymocytes from (A) WT
(C57BL/6; CD8  ), (B) CD8 / KO, (C)
TgCD8(C D)/CD8 / KO, and (D)
TgCD8(C F)/CD8 / KO mice were stained
for CD3, CD4, and CD8. The anti-CD8 
mAb reacts with endogenous Lyt2.2 expressed
by WT mice (A) and Tg Lyt2.1 expressed by
TgCD8(C D) and (C F) mice (C and D).
Endogenous CD8  (Lyt2.2) is not expressed by
the mice in B, C, or D. The left panels (A–D)
show CD3 expression for each strain with the
bar identifying CD3hi cells. The right panels (A–
D) show CD4/CD8 plots for CD3hi cells. The
numbers in specific quadrants represent the per-
centage of cells with the indicated phenotype.688 Temporal Relationship of Stage-specific CD8  Expression and Thymic Selection
plies downregulation of transcription occurs within the
CD3inter or CD3low population.
Fate of DP Thymocytes After Loss of Expression of
TgCD8. While thymocytes which express TgCD8(C F)
on the WT background will continue development be-
yond the CD3low/intermediate stage due to endogenous CD8,
on the KO background there appeared to be a couple of
possible fates depending whether positive selection has oc-
curred by the time TgCD8  expression is lost at the
CD3low/intermediate stage, and continued CD8 expression is
required beyond this stage (i.e., independent of its role in
selection). The left panels of Fig. 1 show CD3 expression
for thymocytes of (Fig. 1 A) WT B6 [CD8  ], (Fig. 1 B)
CD8 / KO, (Fig. 1 C) TgCD8[C D]/CD8 / KO, and
(Fig. 1 D) TgCD8(C F)/CD8 / KO mice. The right
panels show expression of CD4 versus CD8 for CD3hi thy-
mocytes (identified by the bar in the CD3 histograms) (10).
Compared with the low levels of CD4 CD8  cells in WT,
CD8 / , and TgCD8(C D)/CD8 / KO mice (1.5, 2.1,
and 2.2% respectively), there was a 2.5–3-fold increase in
this population in TgCD8(C F)/CD8 / KO mice (Fig. 1
D; 4.6%). This was a reproducible observation and dem-
onstrates that expression of CD8  up to the DP CD3low/
intermediate stage is associated with an increased proportion of
cells that express high levels of CD3 yet are CD4 CD8 .
A possible explanation for their origin is that selection be-
gins before loss of TgCD8(C F) expression and that the
selected cells continue development to “CD8 SP.”
However, as CD8 is unable to be expressed in these
TgCD8(C F)/CD8 / KO cells, they are in fact not
CD8 SP but appear as CD4 CD8  DN.
Peripheral CD3 CD4  T Cells in the Absence of CD8 Ex-
pression Beyond the DP CD3intermediate Thymic Stage. Based
on the above, we examined whether expression of the
CD8 (C F) Tg influenced the distribution of peripheral
T lymphocytes. The left panels of Fig. 2 show that
CD3 CD8  cells were not detected in LNCs of
TgCD8(C F)/CD8 / KO (Fig. 2 D) or CD8 / KO
(Fig. 2 B) mice but were detected in both WT (Fig. 2 A)
and CD8  / KO mice Tg for the CD8(C D) construct
[TgCD8(C D)/CD8 / KO] (Fig. 2 C). The lower level
of CD8  cells for Tg(C D) (5.7%) relative to WT (18.9%)
is due to the lower level of expression of Tg CD8 com-
pared with endogenous CD8 in this line (10).
When analyzed for CD4 expression, a significant CD3 
CD4  population was detected in TgCD8(C D)/CD8 / 
(Fig. 2 C, right; 6.7%) and WT (Fig. 2 A, right;
19.7%) mice but not in CD8 / KO (Fig. 2 B, right; 1.6%).
These CD3 CD4  cells were CD8  for both the WT
(Lyt2.2 ) and TgCD8(C D)/CD8 /  (Lyt2.1 ) samples
(not shown). This, together with the similar percentages of
CD3 CD8  and CD3 CD4  cells for both WT and
TgCD8(C D) strains (18.9 vs. 19.7% for WT; 5.7 vs.
6.7% for TgCD8(C D)/CD8 / ), indicates these are the
same populations. Interestingly, TgCD8(C F)CD8 / KO
LN cells also contained a population of CD3 CD4  cells
(Fig. 2 D, right) similar in size to TgCD8(C D) mice (6.0
vs. 6.7%). The appearance of these cells in the periphery of
TgCD8(C F)/CD8 / , but not CD8 /  KO mice, in-
dicates that they are the result of expression of the
CD8(C F) Tg, in spite of the demonstration that this Tg
is only expressed up to the CD3low/intermediate DP thymic
stage. Examination of the relative abundance of several
TCR V  subfamilies in this population showed no major
distortions in the repertoire (not shown).
Selection of “Rescued” Peripheral CD3 CD4 CD8  Cells.
It was important to determine whether CD3 CD4 CD8 
cells in the periphery of CD8(C F) Tg mice had under-
gone selection for self-MHC restriction and tolerance. To
examine the alloreactive cytotoxic response typical of
CD8  CTLs, primary in vitro cell–mediated lympholysis
assays were performed. LNCs from each of the four groups
were stimulated with H-2d (DBA/2J) spleen cells and
tested in 51Cr-release assays (Fig. 3 A). Due to the absence
of CTLs, there was no killing of H-2d targets by CD8 / 
KO LNCs. In contrast, there was a high level of killing of
these targets by TgCD8(C F)/CD8 / KO LNCs, similar
to TgCD8(C D)/CD8 / KO and WT LNCs. None of
Figure 2. Three-color flow cytometry of peripheral T lymphocytes of
TgCD8 (C F) mice. LNCs of (A) non-Tg WT/CD8  , (B) CD8 / KO,
(C) TgCD8(C D)/CD8 / KO, and (D) TgCD8(C F)/ CD8 / KO
mice were stained for CD3, CD8, and CD4. The anti-CD8  mAb reacts
with Lyt2.2 expressed by WT mice (A) and Tg Lyt2.1 expressed by
TgCD8(C D) and (C F) mice (C and D). Endogenous CD8  (Lyt2.2) is
not expressed by the mice in B, C, or D. The left and right panels (A–D)
show CD3 vs. CD8 and CD3 vs. CD4 profiles. The CD3 CD4  popula-
tion is identified by the circle. The numbers in specific quadrants represent
the percentage of cells with the indicated phenotype.689 Zhang et al. Brief Definitive Report
these cultures lysed H-2b (self) targets. Thus, LNCs from
TgCD8(C F)/CD8 / KO mice demonstrate alloreactive
cytotoxicity to non–self-MHC and tolerance to self-MHC,
implying that they have at least partially undergone positive
and negative selection.
To test the alloreactive response in vivo, skin grafting
was performed using bm1 mice as donor. Relative to H-2b,
bm1 mice carry a single class I difference (H-2Kbm1) which
is recognized by H-2b CD8  CTLs as a transplantation an-
tigen (15). While CD8 / KO (H-2b) mice do not reject
bm1 grafts due to lack of CD8  CTLs (Fig. 3 B),
TgCD8(C F)/CD8 / KO mice rapidly reject these grafts
similar to TgCD8(C D)/CD8 / KO and WT C57BL/6
mice. These results indicate the presence of effector cells in
the periphery of TgCD8(C F)/CD8 / KO mice that re-
spond to MHC class I alloantigens.
“Rescued” Peripheral CD3 CD4 CD8  Population Dis-
plays MHC Class I Restriction. To test whether the pe-
ripheral CD3 CD4 CD8  population in TgCD8(C F)/
CD8 / KO mice is capable of MHC class I–restricted an-
tigen recognition, the response to influenza A infection was
examined. The major anti–flu A CTL response in H-2b
mice is directed toward flu NP peptide 366–374 (NP366–
374) in association with H-2Db (17). To test for this re-
sponse, spleen cells from infected mice of all four groups
were restimulated with H-2b cells pulsed with NP366–374.
After two 6–7-d periods of stimulation, responding cells
were used in 51Cr-release assays. On days 0, 6, and 12, sam-
ples of each culture were stained with anti-CD3 and anti-
CD4 mAbs to follow the CD3 CD4  population (Fig. 4,
A–D). On day 0, 18.9% of WT/CD82  spleen cells were
CD3 CD4  (i.e., CD8 ) (Fig. 4 A, i). At 6 and 12 d, this
population increased to 42.5 and 96.0% of the total (Fig. 4
A, i). The day 12 culture gave high levels of lysis of
NP366–374-pulsed EL4 (H-2b) targets but did not lyse
EL4 pulsed with an irrelevent peptide (NP383–391) or no
peptide (-peptide) (Fig. 4 A, ii). In contrast, there was no
significant expansion of CD3 CD4  cells for cultures from
infected CD8 / KO mice (Fig. 4 B, i) or killing of
NP366–374-pulsed EL4 (Fig. 4 B, ii). Spleen cells from in-
fected TgCD8(C D)/CD8 / KO mice also showed a
NP366–374-specific expansion of the CD3 CD4  popu-
lation from 8.6% on day 0 to 26.5% on day 6 to 91.3% by
day 12 (Fig. 4 C, i). The day 12 culture showed NP366–
375-specific killing of EL4 cells (Fig. 4 C, ii).
Interestingly, there was also a significant expansion of a
CD3 CD4  population in NP366–374-stimulated cultures
from infected TgCD8(C F)/CD8 /  mice, from 8.1% on
Figure 3. (A) Primary in vitro alloreactive
response of TgCD8(C F)/CD8 /  KO mice
against non-self (H-2d) MHC. LNCs from
non-TgWT/CD8 /  (triangles), CD8 /  KO
(diamonds), TgCD8(C D)/CD8 /  KO (squares),
and TgCD8(C F)/CD8 /  KO (round sym-
bols) H-2b mice were stimulated with DBA/2
(H-2d) spleen cells and assayed on Con-A–stim-
ulated H-2b (open symbols) or H-2d (filled sym-
bols) target cells. The effector to target (E:T) ra-
tio and percentage of specific lysis are indicated.
(B) Recognition of H-2Kbm1 tail skin allografts
by TgCD8(C F)/CD8 /  KO mice. Groups
(n   no. of recipients) of non-Tg WT/CD8 / 
( ), CD8 /  KO ( ), TgCD8(C D)/CD8 / 
KO ( ) and TgCD8(C F)/CD8 /  KO ( )
H-2b mice were grafted with tail skin from bm1
mice as described. The plot shows the percent-
age of mice with surviving grafts as a function
of days after transplantation. Control grafts from
H-2 syngeneic (H-2b) mice were not rejected
by any of the groups (not shown).690 Temporal Relationship of Stage-specific CD8  Expression and Thymic Selection
day 0 to 16.5% on day 6 and 67.2% on day 12 (Fig. 4 D, i).
The day 12 culture gave a high level of killing of EL4
pulsed with NP366–374 almost similar to infected WT and
TgCD8(C D)/CD8 / KO mice (Fig. 4 D, ii) but did not
kill EL4 in the absence of peptide or pulsed with irrelevant
peptide. Although the CD3 CD4 (CD8 ) population of
12-d stimulated TgCD8(C F)/CD8 / KO cells for the
experiment shown was slightly less (67.2%) than WT (96%)
and TgCD8(C D)/CD8 / KO (91.3%), additional stud-
ies showed that a few more days of stimulation resulted in
 90% CD3 CD4  cells (not shown).
To compare the response of the CD3 CD4  cells of
each infected group that were specific for NP366–374-
associated H-2Db, MHC-peptide tetramers with this speci-
ficity were used in flow cytometry with anti-CD3 and
anti-CD4 mAbs in a time-course analysis. The plots in Fig.
5 display the staining for the NP366–374/H-2Db tetramer
versus CD4 for CD3  cells of each culture on the indicated
day. On day 0, the results are shown for total CD3  cells
(Fig. 5, A–D, left panels) as well as for the CD3  blast
population (blasts). The level of tetramer staining of
CD3 CD4  cells in the total population (all cells) for each
group on day 0 was only marginally above background
(i.e., 2–3%). As the blast population on day 0 was very low,
it was difficult to detect any tetramer staining above back-
ground. For the WT group (Fig. 5 A), a tetramer-reactive
population of CD3 CD4  cells representing  6.9% of
CD3  blasts first became evident on day 3 (not shown) and
increased on days 4, 6, and 7 to  10.8, 81.8, and 82.9%.
For the CD8 / KO group, from day 0 through day 10
there was no tetramer staining above background (Fig. 5
B). For the TgCD8(C D)/CD8 / KO group, tetramer 
cells first became apparent on the same day as for WT (day
3) but at a lower level (not shown). This population was
still low on day 4 (3.7%) but increased to 30.1 and 43.4%
on days 6 and 7. While all tetramer  cells detected for WT
displayed a single high level of staining (Fig. 5 A, days 4, 6,
and 7), for the TgCD8(C D)/CD8 / KO group there
were two populations, one that stained at a high intensity
(tet hi) similar to the WT group, and another that stained at
a lower level (tet low). The percentage of both tet hi and
tet low populations increased from days 4 to 10 in parallel.
Figure 4. Analysis of the anti–influenza A T cell response of TgCD8(C F)/CD8 /  KO mice. 3 wk after infection, single cell suspensions of (A)
non-Tg WT/CD8  , (B) CD8 / KO, (C) TgCD8(C D)/CD8 / KO, and (D) TgCD8(C F)/CD8 / KO H-2b mice were stimulated for two 6-d
periods with flu peptide NP366–374 and then tested in a 51Cr-release assay. Targets were EL4 (H-2b) cells pulsed with NP366–374 ( NP366–374), an
irrelevant non–H-2b-binding flu peptide NP383–391 ( NP383–391), or no peptide ( peptide) (right panels, (ii) CTL assay]. The E/T ratio and per-
centage of specific lysis are indicated. On days 0, 6 and 12, cell samples of all groups (A–D) were stained for CD3 and CD4. The profiles in (i) show the
results. The numbers in specific quadrants represent the percentage of cells with the indicated phenotype.691 Zhang et al. Brief Definitive Report
For the TgCD8(C F)/CD8 / KO group, tetramer  cells
were not detected on day 3 or 4 (Fig. 5 D) and became ap-
parent on day 5, 2 d later than the WT or TgCD8(C D)/
CD8 / KO groups (not shown). In contrast to both other
groups, tetramer-reactive cells of the TgCD8(C F)/
CD8 / KO group were all of lower intensity and in-
creased from 7% on day 5 (not shown) to 27.1% on day 6
and 40.8% on day 10. Although this proportion increased
further on subsequent days, in several experiments to more
than 85% tetramer , all tetramer-reactive cells on all days
for the (C F) group were of low intensity.
These results demonstrate that peripheral CD3 
CD4 CD8  cells of TgCD8(C F)/CD8 / KO mice
respond to a well defined influenza antigen with significant
expansion of a NP366–374/Db tetramer-reactive popula-
tion which appears similar in some, but not all, respects to
the CD3 CD4 CD8  populations induced in WT and
TgCD8(C D)/CD8 / KO mice. Additional studies
showed that, while the TCR V 8.3 chain dominates this
response among WT CD8  CTLs (17), there is a signifi-
cant reduction in usage of this V  chain in the induced
population of (C F) mice (results not shown).
Discussion
Recent studies indicate that DP to SP coreceptor regula-
tion is more complex than previously assumed, as DP
thymocytes first terminate CD8 expression to yield a
CD4 CD8  intermediate that can then progress to SP
CD4 , or undergo “coreceptor reversal” to SP CD8  (5,
6). Relevant to this are results from ourselves and others
(10, 13, 14) showing expression of CD8 at the DP versus
SP stage depends on distinct transcriptional control se-
quences (cis-mechanisms I and II). These findings raise the
possibility that the CD4 CD8  intermediate (6) corre-
sponds to a transitional stage between inactivation of cis-
mechanism I and activation of cis-mechanism II in cells
progressing to SP CD8 .
Our objective in this paper was to determine, first,
whether cells that have progressed to the stage when CD8
Figure 5. Time-course analysis of flu NP366–374/H-2Db tetramer-reactive CD3 CD4  T cell response of TgCD8(C F)/CD8 /  KO mice. 3 wk
after infection, cell suspensions of (A) non-Tg WT/CD8   , (B) CD8 / KO, (C) TgCD8(C D)/CD8 / KO, and (D) TgCD8(C F)/CD8 / KO
H-2b mice were stimulated with the H-2Db-binding flu peptide NP366–374 for two 7-d periods. On day 0 and each day from day 3 to day 10, samples
of all groups (A–D) were stained with anti-CD3 and anti-CD4 mAbs and the NP366–374/H-2Db tetramer. For day 0, the results are shown for all cells
and for blasts. For days 3 to 10 the results for blasts are shown. The numbers in specific quadrants represent the percentage of cells with the indicated
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cis-mechanism I activity is lost have begun thymic selec-
tion, and second, the fate of these cells in the absence of
subsequent CD8 expression. Compared with CD8 / KO,
there was an increased population of CD3hi thymo-
cytes  that were negative for both CD4 and CD8 in
TgCD8 (C F)/CD8 / KO mice (Fig. 1). Peripheral
lymphoid tissues of these mice also contained an increased
population of CD3 CD4 CD8  cells relative to the other
groups. As the only difference between these mice and
CD8 / KO was expression of the CD8(C F) Tg, the ap-
pearance of these cells in the thymus and periphery is de-
pendent on thymic expression of TgCD8 up to the DP
CD3low/intermediate stage.
Functional analyses of peripheral lymphocytes of (C F)/
CD8 / KO mice demonstrated the presence of cells dis-
playing properties typical of MHC class I–selected CTLs,
including alloreactivity to class I–mismatched skin grafts,
cytotoxicity toward non-self cells in vitro, tolerance toward
self, and MHC class I–restricted recognition of foreign an-
tigen. Although we do not have proof that the increased
population of CD3 CD4 CD8  T cells in (C F)/CD8 / 
KO lymphoid tissues are responsible for mediating the al-
loreactive responses, these activities are not detected in
CD8 / KO mice and thus result from thymic expression
of TgCD8 up to the DP CD3low/intermediate stage. For the
anti-flu response, there was a strong correlation between
induction of CD3 CD4 CD8  cells from spleen and the
level of antigen-specific killing (Fig. 4). Further, these cells
reacted with a tetramer consisting of flu NP366–374 pep-
tide associated with H-2Db, the dominant complex recog-
nized by CTLs in infected H-2b mice (17). Together, these
results show that thymic expression of TgCD8 in (C F)/
CD8 / KO mice is sufficient to give rise to peripheral
CD3 CD4 CD8  T cells that possess a number of func-
tional properties typical of SP CD8  CTLs. As such cells
are not detected in CD8 / KO mice, both positive and
negative selection must have at least partially taken place by
the stage that cis-mechanism I–mediated control of CD8
expression is lost in (C F)/CD8 / KO mice.
Despite the apparent similarity between the CD3 CD4 
CD8  peripheral T cells of (C F)/CD8 / KO mice and
conventional SP CD8  CTLs, there are also differences.
First, although these CD3 CD4 CD8  cells display self-
MHC restriction for foreign antigen, the rate at which they
respond with increased cell numbers after stimulation in
vitro is slightly less than WT or TgCD8(C D) CTLs and
somewhat more variable. We are uncertain whether this is
due to a lower starting frequency, a lower rate of prolifera-
tion, or some other effect. Second, these stimulated (C F)
cells also stain at a lower intensity with the NP366–374/
H-2Db tetramer, suggesting that they may express a lower
level of TCR (Fig. 5). Finally, despite recognizing the same
flu peptide/H-2Db complex, the TCR V 8.3 chain, which
dominates the response of WT mice (17), is expressed by a
much lower proportion of responding (C F) cells. As
V 8.3  T cells are present in the naive repertoire (not
shown), these results suggest that lack of CD8 expression by
responding CTLs influences the choice of TCR V  chain.
Two previous reports showing variant antigenic pep-
tides, but not WT peptide, could mediate selection and
commitment of Tg TCR/CD8 / KO thymocytes in vitro
indicate that CD8 is not absolutely required for develop-
ment of the CD8/CTL lineage (18, 19). Although this may
be so for peptides with increased affinity tested in vitro, the
results here show that expression of CD8 is required for
development of this lineage in vivo, although only up to
the thymic CD3low/intermediate DP stage.
In summary, the presence of self-MHC–restricted and
tolerant CTL-like cells in the periphery of (C F)/CD8 / KO
mice indicates that positive and negative selection, as well as
commitment to the cytotoxic sublineage, must have at least
partially taken place before loss of CD8 expression at the
DP CD3low/intermediate stage. As such, some event induced by
TCR/MHC interactions and selection may be responsible
for triggering the stage-specific changes in CD8  transcrip-
tional control involving cis-mechanisms I and II. Further-
more, our results indicate that development beyond the DP
CD3low/intermediate stage, as well as thymic export, peripheral
survival and cytotoxic function for at least a portion of the
CTL repertoire, does not depend on CD8 being expressed
beyond the thymic CD3low/intermediate stage. However, CD8
expression up to this stage under control of cis-mechanism I
is essential for development of these cells because they are
not detected in CD8 / KO mice.
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